Literature DB >> 23177195

Hsp104 drives "protein-only" positive selection of Sup35 prion strains encoding strong [PSI(+)].

Morgan E DeSantis1, James Shorter.   

Abstract

Structurally distinct, self-templating prion "strains" can encode distinct phenotypes and amplify at different rates depending upon the environment. Indeed, prion strain ensembles can evolve in response to environmental challenges, which makes them highly challenging drug targets. It is not understood how the proteostasis network amplifies one prion strain at the expense of another. Here, we demonstrate that Hsp104 remodels the distinct intermolecular contacts of different synthetic Sup35 prion strains in a way that selectively amplifies prions encoding strong [PSI(+)] and simultaneously eliminates prions encoding weak [PSI(+)]. Hsp104 has reduced ability to fragment prions encoding weak [PSI(+)], but readily converts them to nontemplating forms. By contrast, Hsp104 readily fragments prions encoding strong [PSI(+)], but has reduced ability to eliminate their infectivity. Thus, we illuminate direct mechanisms underpinning how the proteostasis network can drive prion strain selection.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177195      PMCID: PMC3508465          DOI: 10.1016/j.chembiol.2012.09.013

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  45 in total

1.  A yeast prion provides a mechanism for genetic variation and phenotypic diversity.

Authors:  H L True; S L Lindquist
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

Review 2.  Analysis of prion factors in yeast.

Authors:  Yury O Chernoff; Susan M Uptain; Susan L Lindquist
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

3.  Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers.

Authors:  James Shorter; Susan Lindquist
Journal:  Science       Date:  2004-05-20       Impact factor: 47.728

4.  Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits.

Authors:  Heather L True; Ilana Berlin; Susan L Lindquist
Journal:  Nature       Date:  2004-08-15       Impact factor: 49.962

5.  Conformational variations in an infectious protein determine prion strain differences.

Authors:  Motomasa Tanaka; Peter Chien; Nariman Naber; Roger Cooke; Jonathan S Weissman
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

6.  Mechanism of prion loss after Hsp104 inactivation in yeast.

Authors:  R D Wegrzyn; K Bapat; G P Newnam; A D Zink; Y O Chernoff
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+].

Authors:  Y O Chernoff; S L Lindquist; B Ono; S G Inge-Vechtomov; S W Liebman
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

8.  Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae.

Authors:  I L Derkatch; Y O Chernoff; V V Kushnirov; S G Inge-Vechtomov; S W Liebman
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

9.  [Psi(+)] prion generation in yeast: characterization of the 'strain' difference.

Authors:  N V Kochneva-Pervukhova; M B Chechenova; I A Valouev; V V Kushnirov; V N Smirnov; M D Ter-Avanesyan
Journal:  Yeast       Date:  2001-04       Impact factor: 3.239

10.  Continuous quinacrine treatment results in the formation of drug-resistant prions.

Authors:  Sina Ghaemmaghami; Misol Ahn; Pierre Lessard; Kurt Giles; Giuseppe Legname; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2009-11-26       Impact factor: 6.823

View more
  31 in total

1.  Mechanistic Insights into Hsp104 Potentiation.

Authors:  Mariana P Torrente; Edward Chuang; Megan M Noll; Meredith E Jackrel; Michelle S Go; James Shorter
Journal:  J Biol Chem       Date:  2016-01-08       Impact factor: 5.157

Review 2.  Yeast prions and human prion-like proteins: sequence features and prediction methods.

Authors:  Sean M Cascarina; Eric D Ross
Journal:  Cell Mol Life Sci       Date:  2014-01-04       Impact factor: 9.261

3.  Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma.

Authors:  Jeremy J Ryan; Macy L Sprunger; Kayla Holthaus; James Shorter; Meredith E Jackrel
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 4.  Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase.

Authors:  James Shorter; Daniel R Southworth
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

5.  Entropic constraints on the steady-state fitness of competing self-replicators.

Authors:  Owen Leddy; Zhiyue Lu; Aaron R Dinner
Journal:  J Chem Phys       Date:  2018-12-14       Impact factor: 3.488

6.  Potentiating Hsp104 activity via phosphomimetic mutations in the middle domain.

Authors:  Amber Tariq; JiaBei Lin; Megan M Noll; Mariana P Torrente; Korrie L Mack; Oscar Hernandez Murillo; Meredith E Jackrel; James Shorter
Journal:  FEMS Yeast Res       Date:  2018-08-01       Impact factor: 2.796

7.  Locating folds of the in-register parallel β-sheet of the Sup35p prion domain infectious amyloid.

Authors:  Anton Gorkovskiy; Kent R Thurber; Robert Tycko; Reed B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

8.  The Hsp104 N-terminal domain enables disaggregase plasticity and potentiation.

Authors:  Elizabeth A Sweeny; Meredith E Jackrel; Michelle S Go; Matthew A Sochor; Beatrice M Razzo; Morgan E DeSantis; Kushol Gupta; James Shorter
Journal:  Mol Cell       Date:  2015-01-22       Impact factor: 17.970

9.  Therapeutic genetic variation revealed in diverse Hsp104 homologs.

Authors:  Katelyn Sweeney; Hanna Kim; Xiaohui Yan; Zachary M March; Laura M Castellano; Meredith E Jackrel; JiaBei Lin; Edward Chuang; Edward Gomes; Corey W Willicott; Karolina Michalska; Robert P Jedrzejczak; Andrzej Joachimiak; Kim A Caldwell; Guy A Caldwell; Ophir Shalem; James Shorter
Journal:  Elife       Date:  2020-12-15       Impact factor: 8.140

10.  Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.

Authors:  Laura M Castellano; Stephen M Bart; Veronica M Holmes; Drew Weissman; James Shorter
Journal:  Chem Biol       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.